Studio Santa Claus "340 Billion Won Investment Gain from Nexton Bioscience"

[Asia Economy Reporter Jang Hyowon] Studio Santa Claus is showing swift moves by 추진ing a paid-in capital increase worth approximately 60.8 billion KRW to strengthen its cultural content production business and secure funds necessary for drama production.

Additionally, the company sold part of its shares in Nexton Bioscience, which it acquired for about 70 billion KRW last March, to fully repay 34 billion KRW in borrowings and currently holds 2 million remaining shares along with 6,301,860 shares including bonus shares.

Based on the closing price as of the previous day, the valuation of Nexton Bioscience shares is 64.2 billion KRW, recording an appraisal gain exceeding 34 billion KRW.

Baek Juno, CEO of Studio Santa Claus, stated, “Since taking office, we boldly sold all four unlisted subsidiaries we held, restructured and organized the new media business division, and sold the webtoon business to expand film distribution and ancillary rights business,” adding, “This was a decision to focus on drama/film production and distribution business, led by the existing management business.”

He continued, “If funds are secured through the capital increase in the future, they will be used as operating funds necessary for the production of planned dramas and various cultural content,” and added, “The general public paid-in capital increase was a determination for the company to grow one step further, as securing content is important due to the recent expansion of the OTT market.”

This content was produced with the assistance of AI translation services.